Patents by Inventor Fortuna Haviv

Fortuna Haviv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ureas having antiangiogenic activity
    Patent number: 7592466
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: September 22, 2009
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley, Daryl R. Sauer
  • Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
    Patent number: 7432245
    Abstract: Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: October 7, 2008
    Assignee: Abbott Laboratories Inc.
    Inventors: Fortuna Haviv, Bryan K. Erickson, Jack Henkin, Luk C. Li, Fanfeng Ma, Friedrich W. Richter, Yi Shi, Jingfeng Song, Siriporn Toongsuwan
  • TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY
    Publication number: 20080071062
    Abstract: Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Application
    Filed: January 8, 2007
    Publication date: March 20, 2008
    Inventors: Fortuna Haviv, Michael Bradley
  • Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
    Publication number: 20070167376
    Abstract: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Application
    Filed: July 26, 2006
    Publication date: July 19, 2007
    Inventors: Fortuna Haviv, Michael Bradley
  • METHOD OF INHIBITING ANGIOGENESIS
    Publication number: 20070043089
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 22, 2007
    Inventors: FORTUNA HAVIV, MICHAEL BRADLEY, JURGEN DINGES, DARYL SAUER, JACK HENKIN
  • METHOD OF INHIBITING ANGIOGENESIS
    Publication number: 20070032527
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 8, 2007
    Inventors: Fortuna Haviv, Michael Bradley, Jurgen Dinges, Daryl Sauer, Jack Henkin
  • Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
    Patent number: 7169888
    Abstract: Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: January 30, 2007
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley
  • Hexa-, hepta-, and octapeptides having antiangiogenic activity
    Patent number: 7122625
    Abstract: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: October 17, 2006
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley
  • Hepta-, octa-and nonapeptides having antiangiogenic activity
    Publication number: 20060194737
    Abstract: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Application
    Filed: May 5, 2006
    Publication date: August 31, 2006
    Inventors: Fortuna Haviv, Michael Bradley
  • Ureas having antiangiogenic activity
    Publication number: 20060160806
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: October 8, 2004
    Publication date: July 20, 2006
    Inventors: Fortuna Haviv, Michael Bradley, Daryl Sauer
  • Hepta-, Octa-and nonapeptides having antiangiogenic activity
    Patent number: 7067490
    Abstract: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: June 27, 2006
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley
  • TRI-, TETRA-, and penta-peptides having antiangiogenic activity
    Patent number: 7037897
    Abstract: Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: May 2, 2006
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley
  • Di-, tri-, and tetra-peptides having antiangiogenic activity
    Patent number: 7001984
    Abstract: Compounds having the formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: February 21, 2006
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Michael F. Bradley
  • Substituted pyridines having antiangiogenic activity
    Publication number: 20060030557
    Abstract: Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: October 6, 2005
    Publication date: February 9, 2006
    Inventors: Fortuna Haviv, Michael Bradley, Jack Henkin, Jurgen Dinges, Daryl Sauer, Lawrence Kolaczkowski, Anil Vasudevan, David Park
  • Di-, tri-, and tetra-peptides having antiangiogenic activity
    Publication number: 20050215484
    Abstract: Compounds having the formula (SEQ ID NO: 1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 29, 2005
    Inventors: Fortuna Haviv, Michael Bradley
  • Peptide antiangiogenic drugs
    Publication number: 20050124548
    Abstract: Peptides having the formula: A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10 wherein A0 is selected from hydrogen or an acyl group; A10 is a hydroxyl group or an amino acid amide; and A1, A2, A3, A4, A5, A6, A7, A8, and A9 are amino acyl residues as defined herein.
    Type: Application
    Filed: January 23, 2004
    Publication date: June 9, 2005
    Inventors: Jack Henkin, Fortuna Haviv, Michael Bradley, Douglas Kalvin, Andrew Schneider
  • N-alkylated peptides having antiangiogenic activity
    Patent number: 6777535
    Abstract: N-Alkylated peptides of formula (I) Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11  (I), are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: August 17, 2004
    Assignee: Abbott Laboratories
    Inventors: Fortuna Haviv, Jack Henkin, Douglas M. Kalvin, Michael F. Bradley
  • Peptide antiangiogenic drugs
    Patent number: 6774211
    Abstract: Peptides having the formula: A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10 wherein A0 is selected from hydrogen or an acyl group; A10 is a hydroxyl group or an amino acid amide; and A1, A2, A3, A4, A5, A6, A7, A8, and A9 are amino acyl residues as defined herein.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: August 10, 2004
    Assignee: Abbott Laboratories
    Inventors: Jack Henkin, Fortuna Haviv, Michael F. Bradley, Douglas M. Kalvin, Andrew J. Schneider
  • Peptides having antiangiogenic activity
    Patent number: 6753408
    Abstract: Peptides of formula (I) Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11  (I), are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: June 22, 2004
    Inventors: Fortuna Haviv, Jack Henkin, Michael F. Bradley, Douglas M. Kalvin, Andrew J. Schneider
  • Method of inhibiting angiogenesis
    Publication number: 20040116479
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: October 3, 2003
    Publication date: June 17, 2004
    Inventors: Fortuna Haviv, Michael F. Bradley, Jurgen Dinges, Daryl R. Sauer, Jack Henkin